Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder
Christina Shaw,1 William Gibson2 1Division of Geriatric Medicine, University of British Columbia, Vancouver, British Columbia, Canada; 2Division of Geriatric Medicine, University of Alberta, Edmonton, Alberta, CanadaCorrespondence: William Gibson, Division of Geriatric Medicine, University of Albert...
Saved in:
Main Authors: | Shaw C (Author), Gibson W (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mirabegron in the Management of Overactive Bladder Syndrome
by: O'Kane M, et al.
Published: (2022) -
Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
by: I. N. Dyakov, et al.
Published: (2021) -
Profile of mirabegron in the treatment of overactive bladder: place in therapy
by: Sharaf A, et al.
Published: (2017) -
Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
by: Luisa Gracio Ferreira Sartori, et al.
Published: (2023) -
New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
by: Andersson KE
Published: (2013)